Skip to content
Financial Overview Executive Summary This document provides an overview of BrainSAIT's financial model, revenue projections, and key financial metrics for planning and investor communications.
Business Model Revenue Streams Stream % of Revenue Model Platform Subscriptions 70% Recurring Per-Claim Fees 15% Usage-based Professional Services 10% Project-based Training & Support 5% Recurring/One-time
Revenue Recognition Subscriptions: Recognized monthly over term Per-Claim: Recognized as processed Services: Recognized on delivery milestones Training: Recognized on completion Revenue Projections 5-Year Forecast Year ARR (SAR) Growth Customers Year 1 10M - 25 Year 2 30M 200% 75 Year 3 70M 133% 175 Year 4 130M 86% 350 Year 5 220M 69% 600
Revenue by Segment Segment Year 1 Year 3 Year 5 Enterprise 60% 50% 45% Mid-Market 30% 35% 35% SME 10% 15% 20%
Unit Economics Customer Acquisition Cost (CAC) Segment CAC Payback Enterprise 150K SAR 12 months Mid-Market 50K SAR 8 months SME 5K SAR 4 months Blended 40K SAR 9 months
Lifetime Value (LTV) Segment ARPU/Year Lifetime LTV Enterprise 1.5M SAR 5 years 7.5M SAR Mid-Market 300K SAR 4 years 1.2M SAR SME 50K SAR 3 years 150K SAR
LTV/CAC Ratio Segment LTV/CAC Target Enterprise 50x >3x Mid-Market 24x >3x SME 30x >3x Blended 35x >3x
Gross Margin Analysis Revenue Breakdown Component % of Revenue Software Revenue 85% Services Revenue 15%
Cost of Goods Sold Cost Item % of Revenue Infrastructure 10% Support 8% Third-party licenses 5% Services delivery 7% Total COGS 30%
Gross Margin Software: 85% Services: 30% Blended: 70% Operating Expenses Expense Categories Category Year 1 % Rev Year 3 % Rev R&D 4M 40% 14M 20% Sales & Marketing 3M 30% 21M 30% G&A 1.5M 15% 7M 10% Total OpEx 8.5M 85% 42M 60%
R&D Investment Product development: 60% AI/ML research: 25% Platform: 15% Sales & Marketing Sales team: 50% Marketing: 30% Customer success: 20% Profitability Path Path to Profitability Metric Year 1 Year 2 Year 3 Revenue 10M 30M 70M Gross Profit 7M 21M 49M OpEx 8.5M 20M 42M EBITDA (1.5M) 1M 7M EBITDA Margin -15% 3% 10%
Break-Even Analysis Monthly burn: 700K SAR (Year 1) Break-even MRR: 2.5M SAR Expected timing: Month 18 Cash Flow Cash Requirements Phase Duration Investment Seed Completed 5M SAR Series A Month 12 25M SAR Series B Month 36 60M SAR
Use of Funds Series A (25M SAR): - Product development: 40% - Sales & marketing: 35% - G&A: 15% - Working capital: 10%
Key Metrics SaaS Metrics Metric Year 1 Target MRR Growth 25%/mo >20% Gross Margin 70% >70% CAC Payback 9 mo <12 mo LTV/CAC 35x >3x Net Revenue Retention 120% >100% Gross Revenue Retention 95% >90%
Operational Metrics Metric Year 1 Target Magic Number 0.8 >0.75 Burn Multiple 2.0 <2.0 Rule of 40 35 >40
Valuation Considerations Comparable Multiples Metric Healthcare SaaS AI Premium Revenue Multiple 8-12x +20-30% ARR Multiple 10-15x +20-30%
Valuation Drivers Positive: - High growth rate - Strong unit economics - AI technology premium - Saudi market opportunity - Regulatory tailwinds
Risks: - Market concentration - Competitive dynamics - Execution risk - Regulatory changes
Financial Controls Budgeting Process Annual budget cycle Quarterly reviews Monthly reporting Variance analysis Approval Authority Amount Approver <10K SAR Manager 10-50K SAR Director 50-200K SAR VP >200K SAR CEO/CFO
Confidential - For Internal Use Only
Last updated: January 2025
November 21, 2025 November 20, 2025